Anil Bajnath, MD

03/30/2026

Most discussions about physical fitness focus on individual markers—VO₂ max, lab values, or specific measurements.

This study suggests that may be the wrong approach.

Researchers found that very few individual molecular markers strongly correlated with performance. Instead, what consistently explained higher fitness were coordinated biological pathways, including complement/coagulation and arginine metabolism.

This shifts the conversation. It suggests that fitness is not defined by a single measurement, but by how multiple biological systems work together.

It also highlights a broader point in medicine: complex human traits are better understood at the systems level than through isolated variables.



Reference:
https://doi.org/10.1038/s42003-026-09663-2

03/24/2026

What if cancer behaves more like a neural network than a simple mass of cells?

This review highlights a striking shift in our understanding: tumors actively interact with the nervous system. Cancer cells can form synapse-like connections with neurons, respond to neurotransmitters, and even use electrical signaling to promote growth and spread.

This has real implications. It suggests that factors like stress, neural activity, and even certain medications could influence cancer progression. It also opens the door to new treatments—targeting neural signaling alongside traditional therapies like chemotherapy and immunotherapy.

We may be entering an era where treating cancer means addressing not just the tumor, but its neural environment.



Reference:
https://doi.org/10.1038/s41392-025-02364-y

03/23/2026

Medicine has traditionally focused on individual organs, such as the heart, brain, or liver. However, new research shows that these organs function as part of an interconnected system.

A recent review highlights how organs continuously communicate through hormonal signals, immune pathways, metabolites, and neural connections. These interactions help maintain normal physiological balance.

When this communication is disrupted, disease can develop across multiple systems rather than in a single organ. Examples include heart–kidney interactions, gut–brain connections, and liver–kidney syndromes.

Advances in technologies such as multiomics, imaging, and artificial intelligence are now helping researchers better understand these complex networks.

This shift suggests that future medicine may move beyond treating individual organs toward addressing the broader system of interactions that connect them.

Reference:

Organ cross-talk, also known as the organ axis or organ interaction network, plays a vital role in maintaining physiological homeostasis and responding to environmental stimuli. This review comprehensively integrates cutting-edge observations in organ communication research, with a particular focus....

03/20/2026

Cancer is often thought of as a disease driven by genetic mutations, but new research highlights another critical dimension: metabolism.

Tumor cells can reprogram how they process fats, using lipid metabolism to support their growth, survive in challenging environments, and even influence the immune system around them.

This has important implications for treatment. Scientists are now exploring ways to target these metabolic pathways, aiming to disrupt the energy supply that cancer cells depend on.

This shift opens up new possibilities—not only for developing therapies but also for understanding how broader factors, such as diet and metabolic health, may influence cancer progression.

Reference:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12383561/

03/19/2026

Menopause is often discussed in terms of symptoms like hot flashes or sleep disturbances, but it also marks an important shift in metabolic health.

Research shows that this transition is associated with increased abdominal fat, changes in cholesterol levels, and a higher risk of type 2 diabetes and cardiovascular disease.

Hormone replacement therapy (HRT), while commonly used to manage symptoms, also plays a role in these metabolic processes. Its effects on fat distribution, blood sugar control, and cardiovascular risk can vary depending on when it is started and how it is administered.

This highlights an important perspective: menopause care is not only about symptom relief, but also an opportunity to support long-term health and reduce future disease risk.

Reference:
https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.70214

03/17/2026

Many chronic diseases, including type 2 diabetes, develop gradually over years but are typically detected through occasional clinical tests. This means early changes in the body often go unnoticed.

New research highlighted in Nature suggests that data from wearable devices—such as activity levels, sleep patterns, and heart rate—can help detect early signs of insulin resistance long before traditional tests identify a problem.

By analyzing continuous physiological data collected during everyday life, researchers were able to identify patterns that reflect increasing metabolic strain.

This approach could open the door to earlier interventions focused on prevention, potentially reducing the long-term burden of metabolic disease.

Reference:
https://www.nature.com/articles/d41586-026-00380-8

Patterns in continuous data from wearable devices could reveal early metabolic dysfunction long before routine clinical tests detect it.

03/16/2026

Cognitive decline is often associated with ageing of the brain, but new research suggests that the gut microbiome may also play a role.

Studies in mice show that transferring gut microbes from older animals into young ones can impair memory performance. Researchers identified a specific bacterium, Parabacteroides goldsteinii, that appears to contribute to these effects.

The mechanism involves molecules produced by gut microbes that activate immune pathways and interfere with vagus nerve signaling, ultimately affecting brain regions involved in learning and memory.

These findings highlight how the gut–brain axis may influence cognitive ageing and raise new questions about whether microbiome-targeted interventions could help protect brain health.

Reference:
https://www.nature.com/articles/d41586-026-00492-1

As mice age, changes in the microorganisms in their guts contribute to cognitive decline by altering signalling between the gut and brain.

03/12/2026

Chronic abdominal pain is one of the most challenging symptoms experienced by people with inflammatory bowel disease (IBD). Interestingly, many patients continue to experience pain even when intestinal inflammation is well controlled.

Recent research suggests that the explanation may lie in changes within the gut–brain pain pathway. Sensory nerves in the gut can become sensitized, and pain signaling may be amplified at multiple levels—from the intestine to the spinal cord and brain.

These neuroplastic changes mean that pain can persist even when inflammation improves, highlighting the need for treatment strategies that address both inflammation and the neural mechanisms of chronic pain.

Article:
https://www.nature.com/articles/s41575-025-01139-8

03/11/2026

Microglia are often described as the immune cells of the brain, but new research suggests they also play an important role in shaping neural circuits during development.

A study in Nature Neuroscience found that microglia actively remove excess myelin sheaths produced by oligodendrocytes. This process helps refine neural networks by ensuring that myelination occurs only where it is needed.

Interestingly, the amount of myelin removed appears to depend on neuronal activity, suggesting that active neural circuits influence how the brain’s wiring is optimized.

These findings highlight a broader role for microglia in brain development—not just in immune defense, but also in guiding the formation of efficient neural communication.

Article:
https://www.nature.com/articles/s41593-020-0654-2

03/10/2026

Most gene-editing technologies focus on altering DNA sequences directly. However, an emerging approach called epigenetic editing aims to treat disease without changing the genetic code.

Using programmable systems such as modified CRISPR platforms, scientists can target specific genes and modify the epigenetic marks that regulate gene activity. By rewriting these regulatory signals, researchers can switch genes on or off while leaving the DNA sequence intact.

Because many diseases arise from abnormal gene expression rather than permanent genetic mutations, this approach could open new therapeutic possibilities.

Article:
https://www.nature.com/articles/s41573-025-01323-0

03/09/2026

We often hear about the role of the gut microbiome in cancer. A new study suggests that the story may involve collaboration between different types of microbes.

Researchers found that the fungus Candida albicans can work together with the bacterium Fusobacterium nucleatum to promote colorectal cancer progression. The fungus forms invasive hyphae that help the bacteria pe*****te the protective mucus barrier in the colon, allowing them to reach tumor tissue more effectively.

This interaction is mediated through a specific molecular mechanism involving proteins called Flo9 and RadD.

The findings highlight how cancer biology may involve microbial ecosystems rather than individual pathogens, opening new questions about the role of the microbiome and mycobiome in disease.

You can read the study here:
https://pubmed.ncbi.nlm.nih.gov/41759520/

03/05/2026

Fluid overload is a frequent challenge in critically ill patients after resuscitation. Removing excess fluid using ultrafiltration during renal replacement therapy can improve congestion—but doing so safely is complex.

Research suggests a U-shaped relationship between ultrafiltration rate and mortality. Removing too little fluid leaves patients congested, while removing too much can lead to hemodynamic instability and tissue hypoperfusion.

A new framework proposes that tolerance to ultrafiltration depends on four key physiological systems: vascular refilling, cardiac function, venous capacitance, and systemic vascular resistance.

This shifts the approach in critical care toward personalized fluid removal strategies, guided by patient physiology rather than fixed protocols.

Ultimately, the challenge in the ICU is not simply removing fluid—but determining how much fluid each patient can safely tolerate losing.

Check the article here: https://link.springer.com/article/10.1186/s13054-026-05836-x?fbclid=IwRlRTSAQVjp9leHRuA2FlbQIxMQBzcnRjBmFwcF9pZAo2NjI4NTY4Mzc5AAEedZd4SDjU9LaomXhlTaSNMkXzRv3BNzmmqIvrhLghJx80y3TzpS6puA-eE5Q_aem__UAiT9Rnfq-HyEoSMLoDBw